Page last updated: 2024-09-03

s 312 and Goldblatt Syndrome

s 312 has been researched along with Goldblatt Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujitomo, H; Hirohata, S; Kagawa, H; Kawakami, M; Masui, M; Matsumura, S; Matsuura, E; Shima, K; Ueda, M; Umeda, T1

Other Studies

1 other study(ies) available for s 312 and Goldblatt Syndrome

ArticleYear
Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs.
    Arzneimittel-Forschung, 1993, Volume: 43, Issue:12

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cerebrovascular Disorders; Desoxycorticosterone; Dihydropyridines; Dogs; Female; Heart Rate; Hypertension; Hypertension, Renal; Hypertension, Renovascular; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar; Renin

1993